Laurel Wealth Advisors (North Carolina)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$569K	Buy	9,537 +8,968	+1,576%	+$535K	0.01%	322
2025 Q1	$8.75K	Hold	569	–	–	﹤0.01%	487
2024 Q4	$12.5K	Hold	569	–	–	﹤0.01%	466
2024 Q3	$10.3K	Buy	569 +333	+141%	+$6K	﹤0.01%	458
2024 Q2	$3.84K	Buy	+236	New	+$3.84K	﹤0.01%	509